Instead of subsiding after the antigen has been destroyed, this response escalates, causing inflammation that damages healthy tissues. If researchers can answer this question, they can begin to develop therapies that control them. Thanks to the development of new molecular techniques and rodent models of IBD, the pace of immunological research has accelerated during the past decade. Investigators have identified many immune system components and learned how they interact with one another.
T cells produce.
Continued progress in this critical field will yield important data that could help researchers uncover the cause of IBD, and ultimately, find a cure.